DEBERNARDI MM; DIAZ ALBUJA, JA; STERLE HA; PAULAZO MA; DIAZ FLAQUÉ MC; CAMPOS HAEDO MN; GONZALEZ G; ROSEMBLIT C; CREMASCHI GA; CAYROL F

THYROID HORMONES (THS) ACTING THROUGH INTEGRIN ΑVΒ3 INDUCE ONCOGENIC SIGNALING PATHWAYS INVOLVED IN T CELL LYMPHOMA (TCL) PROGRESSION

REUNIÓN DE SOCIEDADES DE BIOCIENCIAS 2022

Año: 2022;

CAYROL F; STERLE HA; DEBERNARDI MM; GONZALEZ G; DIAZ ALBUJA, JA; CAMPOS HAEDO MN; CREMASCHI GA

THYROID HORMONES INFLUENCE METASTATIC AND NON-METASTATIC MELANOMA PROGRESSION

REUNIÓN DE SOCIEDADES DE BIOCIENCIAS 2022

Año: 2022;

DIAZ ALBUJA, JA; FAGÚNDEZ, PABLO; TOSAR, JUAN PABLO; CAMPOS HAEDO MN; DEBERNARDI MM; GONZALEZ G; MENAY F; CREMASCHI GA; DIAZ FLAQUÉ MC

ANALYSIS OF THYROID HORMONE EFFECTS ON THE RELEASE OF EXTRACELLULAR VESICLES AND THEIR ROLE IN CHEMOTHERAPY RESPONSE IN BREAST CANCER

REUNIÓN DE SOCIEDADES DE BIOCIENCIAS 2022

Año: 2022;

STERLE HA; CAYROL F; DEBERNARDI MM; GONZALEZ G; CREMASCHI GA

THYROID HORMONES REGULATE CELL PROLIF- ERATION AND ANTITUMOR IMMUNITY IN MELANOMA

REUNIÓN DE SOCIEDADES DE BIOCIENCIAS 2021

Año: 2021;

DEBERNARDI MM; DIAZ ALBUJA, JA; STERLE H; PAULAZO A; DIAZ FLAQUÉ MC; ROSEMBLIT C; CREMASCHI GA; CAYROL F

Thyroid hormones (THs) induce oncogenic signaling pathways involved in T cell lymphoma (TCL) progression

SAFIS-ALACF 2021

Año: 2021;

CAMPOS HAEDO MN; DIAZ FLAQUÉ MC; DIAZ ALBUJA JA; PERONA M; DEBERNARDI MM; CAYROL MF; BARREIRO ARCOS ML; STERLE HA; JUVENAL GJ; CREMASCHI GA; ROSEMBLIT C

BRAF INHIBITION DIMINISHES CELL VIABILITY VIA PKC ALPHA (PKCA) IN THYROID CANCER CELLS

Reunion Conjunta de Sociedades de Biociencias 2020

Año: 2020;

PROCOPIO C; DEBERNARDI MM; ROSEMBLIT C; CREMASCHI GA; CAYROL MF

THYROID HORMONE (TH) IMPACT ON THE PRO-LIFERATION OF ON HUMAN MELANOMA (ME) CELLS AND TREATMENT WITH THE SYNTHETIC REXINOID BEXAROTENE.

Reunion Conjunta de Sociedades de Biociencias 2020

Año: 2020;

ROSEMBLIT C; DIAZ-FLAQUÉ MC; DÍAZ ALBUJA JA; BARREIRO ARCOS ML; CAYROL MF; STERLE HA; DEBERNARDI MM; PAULAZO MA; KLECHA A; CREMASCHI GA

Molecular mechanisms of action in TSH-mediated regulation of thyroid cancer cells. Role of PKC

Reunion Conjunta de Sociedades de Biociencias 2019

Año: 2019;

DEBERNARDI MM; DIAZ ALBUJA JA; STERLE HA; DIAZ FLAQUÉ MC; ROSEMBLIT C; PAULAZO MA; CERCHIETTI L; CREMASCHI GA; CAYROL MF

Implications of thyroid hormones (TH) in rexinoids anti-lymphoma activity: integrin alpha V Beta 3 inhibition in the treatment of T cell lymphoma (TCL) with bexarotene

Reunion Conjunta de Sociedades de Biociencias 2019

Año: 2019;

DIAZ ALBUJA JA; ROSEMBLIT C; DEBERNARDI MM; CAYROL MF; STERLE HA; PAULAZO MA; CREMASCHI GA; DIAZ FLAQUÉ MC

THYROID HORMONES EFFECTS IN BEXAROTENE TREATMENT OF BREAST CANCER CELLS

Reunion Conjunta de Sociedades de Biociencias 2019

Año: 2019;

DEBERNARDI MM; CAYROL MF; DÍAZ ALBUJA JA; STERLE HA; ROSEMBLIT C; CREMASCHI GA

Rexinoids for the treatment of T cell lymphoma (TCL): implications of thyroid hormones (TH) in bexarotene anti-lymphoma activity

Reunion Conjunta de Sociedades de Biociencias 2018

Año: 2018;

CAYROL F; DEBERNARDI M; REVUELTA V; PAULAZO A; CALVO-VIDAL MN; PHILLIP JM; STERLE H; DIAZ FLAQUÉ MC; CREMASCHI GA; CERCHIETTI L

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

59th American Society of Hematology (ASH) Annual Meeting Dec 2017

Año: 2017;

CAYROL F; DEBERNARDI M; REVUELTA V; PAULAZO A; CALVO-VIDAL MN; PHILLIP JM; STERLE H; DIAZ FLAQUÉ MC; CERCHIETTI L; CREMASCHI GA

BEXAROTENE TREATMENT FOR CUTANEOUS T CELL LYMPHOMA (CTCL): IMPLICATIONS OF THYROID HORMONE (TH) REPLACEMENT IN THE ANTI-LYMPHO- MA ACTIVITY AND IN THE ANTITUMORAL IMMUNE RESPONSE

Reunión Conjunta de Sociedades de BioCiencias 2017

Año: 2017;

DEBERNARDI M; PAULAZO A; STERLE H; DIAZ FLAQUÉ MC; CERCHIETTI L; CREMASCHI GA; CAYROL F

THYROID HORMONE MEMBRANE RECEPTOR INHIBITION IN THE TREATMENT WITH REXINOIDS OF CUTANEOUS T CELL LYMPHOMA

Reunion Conjunta de Sociedades de Biociencias 2017

Año: 2017;

CAYROL F; REVUELTA V; PAULAZO A; DEBERNARDI M; STERLE H; DIAZ FLAQUÉ MC; CERCHIETTI L; CREMASCHI GA

Inhibition of the integrin alphaV beta3 improves the effect of bexarotene in the treatment of cutaneous T-cell lymphoma (CTCL).

American Association for Cancer Research Annual Meeting

Año: 2017;

CAYROL F; REVUELTA V; DEBERNARDI M; DIAZ FLAQUÉ MC; PAULAZO A; STERLE H; CERCHIETTI L; CREMASCHI GA

Effect of thyroid hormone membrane receptor inhibition in the treatment with rexinoids of Cutaneous T cell lymphoma.

LXI Reunión Científica Anual de la Sociedad. Argentina de Investigación Clínica

Año: 2016;